Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)
Introduction Scabies is a significant contributor to global morbidity, affecting approximately 200 million people at any time. Scabies is endemic in many resource-limited tropical settings. Bacterial skin infection (impetigo) frequently complicates scabies infestation in these settings. Community-wi...
Saved in:
| Main Authors: | Michael Marks, John Kaldor, Oliver Sokana, Tibor Schuster, Ross Andrews, Susanna J Lake, Sophie L Phelan, Daniel Engelman, Titus Nasi, Dickson Boara, Christina Gorae, Anneke C Grobler, Millicent H Osti, Margot J Whitfeld, Lucia Romani, Andrew Steer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/8/e037305.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Prevalence of Scabies and Impetigo in the Solomon Islands: A Population-Based Survey.
by: Daniel S Mason, et al.
Published: (2016-06-01) -
Long Term Control of Scabies Fifteen Years after an Intensive Treatment Programme.
by: Michael Marks, et al.
Published: (2015-12-01) -
Effect of ivermectin on scabies: a retrospective evaluation
by: Ömer Karakoyun, et al.
Published: (2025-07-01) -
A framework for scabies control.
by: Daniel Engelman, et al.
Published: (2021-09-01) -
Comparative Effectiveness of Ivermectin and Permethrin in the Treatment of Scabies Diagnosed in the Emergency Department
by: Tuba Betül Ümit, et al.
Published: (2025-04-01)